Study Links IBS Medications to Slight Increase in Mortality Risk Over 20-Year Analysis

A recent study has identified a potential link between certain medications commonly prescribed for irritable bowel syndrome (IBS) and a slight increase in the risk of death. Researchers from Cedars-Sinai Health Sciences University conducted the extensive investigation, which analyzed nearly 20 years of electronic health records from over 650,000 adults in the United States diagnosed with IBS. The findings, published in *Communications Medicine*, represent the largest real-world study to date examining the long-term safety of treatments for IBS.

The study highlights that some medications, including antidepressants often used to manage IBS symptoms, may carry a small but measurable increase in mortality risk. Investigators utilized comprehensive data spanning two decades to assess treatment outcomes and associated risks. This large-scale analysis provides new insights into the potential implications of widely used therapies for IBS patients. Further research may be needed to better understand these findings and their clinical significance.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI